Nearly half of the world’s population is at risk of malaria.
In 2016, an estimated 216 million cases of malaria occurred worldwide and there were an estimated 445,000 deaths from malaria globally.Learn more
Fosun Pharma’s Innovative drug Artesun®
Artesun® (artesunate for injection), an innovative drug of Fosun Pharma, is fully IP-protected with guaranteed quality recommended by the WHO for severe malaria treatment. It has become the internationally recognized reference drug for treating severe malaria. The scale-up of effective tools in malaria prevention and control measures, including the adoption of injectable artesunate have led to a 18% reduction of the incidence rate of malaria between 2010-2016, with a continuous decrease of malaria mortality globally.
Innovation for Good Health
Staying true to its brand philosophy of “Innovation for Good Health”, Fosun Pharma has been relying on innovation to drive further growth. We commit to make efforts to provide better products and services to patients in the future, and work towards the great vision of building a “malaria-free world”.Discovery more
Vials of injectable artesunate